These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
867 related items for PubMed ID: 26220125
21. Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a long-term follow-up. Huang S, Yu J, Liang P, Yu X, Cheng Z, Han Z, Li Q. Eur J Radiol; 2014 Mar; 83(3):552-8. PubMed ID: 24418287 [Abstract] [Full Text] [Related]
22. [Efficacy of microwave ablation in treatment of hepatocellular carcinoma within the Milan criteria: a report of 696 cases]. Wang YM, Qian GJ, Xu Y, Wang N, Sheng YH. Zhonghua Gan Zang Bing Za Zhi; 2017 May 20; 25(5):344-348. PubMed ID: 28763840 [Abstract] [Full Text] [Related]
23. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L, Xiao Q. Radiology; 2005 Apr 20; 235(1):299-307. PubMed ID: 15731369 [Abstract] [Full Text] [Related]
24. Long-term outcomes following microwave ablation for liver malignancies. Leung U, Kuk D, D'Angelica MI, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, Fong Y. Br J Surg; 2015 Jan 20; 102(1):85-91. PubMed ID: 25296639 [Abstract] [Full Text] [Related]
26. Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation. Facciorusso A, Del Prete V, Antonino M, Crucinio N, Neve V, Di Leo A, Carr BI, Barone M. Dig Liver Dis; 2014 Nov 20; 46(11):1014-9. PubMed ID: 25085684 [Abstract] [Full Text] [Related]
27. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation. Seo JY, Kim W, Kwon JH, Jin EH, Yu SJ, Kim HY, Jung YJ, Kim D, Kim YJ, Yoon JH, Lee HS. Liver Int; 2013 Jul 20; 33(6):884-93. PubMed ID: 23461618 [Abstract] [Full Text] [Related]
28. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. Kim YS, Lim HK, Rhim H, Lee MW, Choi D, Lee WJ, Paik SW, Koh KC, Lee JH, Choi MS, Gwak GY, Yoo BC. J Hepatol; 2013 Jan 20; 58(1):89-97. PubMed ID: 23023009 [Abstract] [Full Text] [Related]
29. Percutaneous microwave ablation for HCV-related hepatocellular carcinoma: Efficacy, safety, and survival. Darweesh SK, Gad AA. Turk J Gastroenterol; 2019 May 20; 30(5):445-453. PubMed ID: 31060999 [Abstract] [Full Text] [Related]
30. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma]. Wu J, Chen MH, Yang W, Wu W, Yan K. Zhonghua Gan Zang Bing Za Zhi; 2012 Apr 20; 20(4):256-60. PubMed ID: 22964144 [Abstract] [Full Text] [Related]
31. Microwave ablation for hepatic malignancies: a multiinstitutional analysis. Groeschl RT, Pilgrim CH, Hanna EM, Simo KA, Swan RZ, Sindram D, Martinie JB, Iannitti DA, Bloomston M, Schmidt C, Khabiri H, Shirley LA, Martin RC, Tsai S, Turaga KK, Christians KK, Rilling WS, Gamblin TC. Ann Surg; 2014 Jun 20; 259(6):1195-200. PubMed ID: 24096760 [Abstract] [Full Text] [Related]
32. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors. Ma S, Ding M, Li J, Wang T, Qi X, Shi Y, Ming Y, Chi J, Wang Z, Tang X, Cui D, Zhang Y, Zhai B. J Cancer Res Clin Oncol; 2017 Jan 20; 143(1):131-142. PubMed ID: 27650934 [Abstract] [Full Text] [Related]
33. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas. Ohmoto K, Yoshioka N, Tomiyama Y, Shibata N, Kawase T, Yoshida K, Kuboki M, Yamamoto S. J Gastroenterol Hepatol; 2009 Feb 20; 24(2):223-7. PubMed ID: 18823439 [Abstract] [Full Text] [Related]
34. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Lu MD, Yin XY, Xie XY, Xu HX, Xu ZF, Liu GJ, Kuang M, Zheng YL. Br J Surg; 2005 Nov 20; 92(11):1393-8. PubMed ID: 16044409 [Abstract] [Full Text] [Related]
35. Negative hepatitis B envelope antigen predicts intrahepatic recurrence in hepatitis B virus-related hepatocellular carcinoma after ablation therapy. Chung GE, Kim W, Lee JH, Kim YJ, Yoon JH, Lee JM, Lee JY, Kim SH, Kim D, Lee HS. J Gastroenterol Hepatol; 2011 Nov 20; 26(11):1638-45. PubMed ID: 22011297 [Abstract] [Full Text] [Related]
36. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound. Zhang W, Luo E, Gan J, Song X, Bao Z, Zhang H, Chen M. World J Surg Oncol; 2017 Jul 05; 15(1):122. PubMed ID: 28679433 [Abstract] [Full Text] [Related]
37. Microwave ablation with cooled-tip electrode for liver cancer: an analysis of 160 cases. Zhang X, Zhou L, Chen B, Hu S, Wachtel MS, Frezza EE. Minim Invasive Ther Allied Technol; 2008 Jul 05; 17(5):303-7. PubMed ID: 18942003 [Abstract] [Full Text] [Related]
38. Topographical impact of hepatitis B-related hepatocellular carcinoma on local recurrence after radiofrequency ablation. Kim JS, Kim W, So YH, Yu SJ, Kim BG. J Clin Gastroenterol; 2014 Jan 05; 48(1):66-72. PubMed ID: 23751848 [Abstract] [Full Text] [Related]
39. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, Iwakiri H, Uto H, Kato J, Ido A, Hayashi K, Tsubouchi H. J Gastroenterol; 2003 Jan 05; 38(10):977-81. PubMed ID: 14614605 [Abstract] [Full Text] [Related]
40. Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach: A retrospective comparative study. Lee KF, Wong J, Hui JW, Cheung YS, Chong CC, Fong AK, Yu SC, Lai PB. Asian J Surg; 2017 Jul 05; 40(4):301-308. PubMed ID: 26922631 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]